The HIV complex Delstrigo is available in general hospitals. According to related industries, Delstrigo, a fixed-dose HIV tx taken once a day by MSD Korea, has passed the D.C. of medical institutions such as Sinchon Severance Hospital, National Medical Center, Pusan National University, Kyungpook National University, Chonnam National University, and Seoul Medical Center. Due to the nature of HIV drugs, as prescriptions are mainly made at national hospitals, landing was conducted mainly at major national hospitals.

The drug was approved in Korea in January 2020 and has been on the list since January last year. Delstrigo's indication is "treatment of human immunodeficiency virus (HIV-1) infection in ad